Exact Mass: 209.17665259999998
Exact Mass Matches: 209.17665259999998
Found 143 metabolites which its exact mass value is equals to given mass value 209.17665259999998,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Ethirimol
C11H19N3O (209.15280439999998)
INTERNAL_ID 356; CONFIDENCE standard compound; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3299; ORIGINAL_PRECURSOR_SCAN_NO 3298 CONFIDENCE standard compound; INTERNAL_ID 356; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6953; ORIGINAL_PRECURSOR_SCAN_NO 6949 CONFIDENCE standard compound; INTERNAL_ID 356; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3301; ORIGINAL_PRECURSOR_SCAN_NO 3298 CONFIDENCE standard compound; INTERNAL_ID 356; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6959; ORIGINAL_PRECURSOR_SCAN_NO 6955 CONFIDENCE standard compound; INTERNAL_ID 356; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3299; ORIGINAL_PRECURSOR_SCAN_NO 3298 CONFIDENCE standard compound; INTERNAL_ID 356; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3377; ORIGINAL_PRECURSOR_SCAN_NO 3375 CONFIDENCE standard compound; INTERNAL_ID 356; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3303; ORIGINAL_PRECURSOR_SCAN_NO 3299 CONFIDENCE standard compound; INTERNAL_ID 356; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6985; ORIGINAL_PRECURSOR_SCAN_NO 6980 CONFIDENCE standard compound; INTERNAL_ID 356; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3289; ORIGINAL_PRECURSOR_SCAN_NO 3286 CONFIDENCE standard compound; INTERNAL_ID 356; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6930; ORIGINAL_PRECURSOR_SCAN_NO 6927 CONFIDENCE standard compound; INTERNAL_ID 356; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3299; ORIGINAL_PRECURSOR_SCAN_NO 3296 CONFIDENCE standard compound; INTERNAL_ID 356; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6952; ORIGINAL_PRECURSOR_SCAN_NO 6951 CONFIDENCE standard compound; INTERNAL_ID 356; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 6974; ORIGINAL_PRECURSOR_SCAN_NO 6972
Minoxidil
C - Cardiovascular system > C02 - Antihypertensives > C02D - Arteriolar smooth muscle, agents acting on > C02DC - Pyrimidine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D - Dermatologicals KEIO_ID M035; [MS2] KO009058 KEIO_ID M035
Minoxidil
Minoxidil is only found in individuals that have used or taken this drug. It is a potent direct-acting peripheral vasodilator (vasodilator agents) that reduces peripheral resistance and produces a fall in blood pressure. (From Martindale, The Extra Pharmacopoeia, 30th ed, p371)Minoxidil is thought to promote the survival of human dermal papillary cells (DPCs) or hair cells by activating both extracellular signal-regulated kinase (ERK) and Akt and by preventing cell death by increasing the ratio of BCl-2/Bax. Minoxidil may stimulate the growth of human hairs by prolonging anagen through these proliferative and anti-apoptotic effects on DPCs. Minoxidil, when used as a vasodilator, acts by opening adenosine triphosphate-sensitive potassium channels in vascular smooth muscle cells. This vasodilation may also improve the viability of hair cells or hair follicles. C - Cardiovascular system > C02 - Antihypertensives > C02D - Arteriolar smooth muscle, agents acting on > C02DC - Pyrimidine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D - Dermatologicals
Labienoxime
Labienoxime is a fragrance ingredient with a blackcurrant-like arom Fragrance ingredient with a blackcurrant-like aroma
2,5-Dimethoxy-4-methylamphetamine
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D006213 - Hallucinogens
Bamethan
C - Cardiovascular system > C04 - Peripheral vasodilators > C04A - Peripheral vasodilators > C04AA - 2-amino-1-phenylethanol derivatives C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
2,5-Dimethoxy-4-methylamphetamine
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D006213 - Hallucinogens
3c-methyl-(4ar,10at,10bc)-decahydro-pyrano[2,3-g]indolizin-1-one|Elaeokanin D|Elaeokanine D
Nicotinoylcholine
[C11H17N2O2]+ (209.12899620000002)
IPB_RECORD: 231; CONFIDENCE confident structure
(8S,Z)-8-methyl-6-(2-methylpropylidene)octahydroindolizin-8-ol
(1S,Z)-3-(2-methylpropylidene)octahydro-2H-quinolizin-1-ol
1-Propanamine,3-(tricyclo[3.3.1.13,7]dec-1-yloxy)-
1-(2,4-DIMETHYL-PHENOXY)-3-METHYLAMINO-PROPAN-2-OL
N-(2-piperazin-1-ylethyl)-N-prop-2-enylprop-2-en-1-amine
Fepradinol
D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
3-Fluoro-4-(4-methyl-1-piperazinyl)aniline
C11H16FN3 (209.13281879999997)
3-(4-Isopropylphenyl)-1-methyl-1-(2H3)methylurea
C12H15D3N2O (209.16073733399998)
4-AMINO-5-IODO-2-(TRIFLUOROMETHYL)-BENZENECARBONITRILE
2-(Cyclopropylmethyl)hexahydrocyclopenta[c]-pyrrole-3a(1H)-carboxylic acid
1-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-1,2,3-triazole
1,2,3,6-Tetrahydropyridine-4-boronic acid pinacol ester
C11H20BNO2 (209.15870100000004)
2,6-Octadien-1-amine,N,N-diethyl-3,7-dimethyl-, (2Z)-
3-methoxy-N-[(4-methoxyphenyl)methyl]propan-1-amine
Ethanol, 2-[[1-(4-ethoxyphenyl)ethyl]amino]- (9CI)
1-bromo-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecadeuteriooctane
3-(Cyclohexyliminomethylideneamino)-N,N-dimethylpropan-1-amine
3-methoxy-N-[(3-methoxyphenyl)methyl]propan-1-amine
4 (1H)-Pyrimidinone, 2-amino-5-hexyl-6-methyl-
C11H19N3O (209.15280439999998)
N-(1-ADAMANTYL)HYDRAZINECARBOXAMIDE
C11H19N3O (209.15280439999998)
(4-METHOXY-BENZYL)-(2-METHOXY-1-METHYL-ETHYL)-AMINE
tert-butyl 3,4,5-trimethyl-1H-pyrrole-2-carboxylate
Mirogabalin
N - Nervous system > N02 - Analgesics > N02B - Other analgesics and antipyretics > N02BF - Gabapentinoids C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic
2-Octyl cyanoacrylate
D001697 - Biomedical and Dental Materials > D014014 - Tissue Adhesives
[6-Aminomethyl-3-ethylbicyclo[3.2.0]hept-3-en-6-yl]acetic acid
5,5-Dimethyl-3-(morpholin-4-yl)cyclohex-2-en-1-one
1-Carboxyethylaminomethyl-4-Aminomethylbenzene
C11H17N2O2+ (209.12899620000002)
Bamethan
C - Cardiovascular system > C04 - Peripheral vasodilators > C04A - Peripheral vasodilators > C04AA - 2-amino-1-phenylethanol derivatives C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
Trimethyl-[2-(pyridine-3-carbonyloxy)ethyl]azanium
C11H17N2O2+ (209.12899620000002)
(1E,3S,4Z)-7-amino-1-[3-[(E)-prop-1-enyl]oxiran-2-yl]hepta-1,4-dien-3-ol
N,N-diethyl-4-methoxy-1-pyridin-1-iumcarboxamide
C11H17N2O2+ (209.12899620000002)
(6R,7S,9S)-2-imino-7,9-dimethyl-1,3-diazaspiro[5.5]undecan-4-one
C11H19N3O (209.15280439999998)
An azaspiro compound resulting from the spiro-fusion of 2-imino-1,3-diazinan-4-one at position 6 with 1,3-dimethylcyclohexane. It is a marine metabolite isolated from Vietnamese pufferfish Tetraodon biocellatus and a potential intermediate in the biosynthetic pathway leading to the synthesis of tetrodotoxin.
1-(5-piperidin-1-ium-2-yl-3,4-dihydro-2H-pyridin-1-yl)ethanone
oxido-[(2E)-2-[(2E,4E,7E)-undeca-2,4,7-trienylidene]hydrazinyl]azanium
C11H19N3O (209.15280439999998)
(3S,4R)-3-ethyl-4-[(3-methyl-1H-imidazol-3-ium-4-yl)methyl]-2-oxolanone
C11H17N2O2+ (209.12899620000002)
n-(2-methylpropyl)-3-(3-oxocyclopent-1-en-1-yl)propanimidic acid
n-[2-(undeca-2,4-dien-1-ylidene)hydrazin-1-ylidene]hydroxylamine
C11H19N3O (209.15280439999998)
n-[(e)-{2-[(1s)-2,2,3-trimethylcyclopent-3-en-1-yl]ethylidene}amino]carbamimidic acid
C11H19N3O (209.15280439999998)
8-azabicyclo[3.2.1]octan-3-yl 2-methylbut-2-enoate
n-[(2e)-2-[(2e,4e)-undeca-2,4-dien-1-ylidene]hydrazin-1-ylidene]hydroxylamine
C11H19N3O (209.15280439999998)
(1r,3s,5s)-8-azabicyclo[3.2.1]octan-3-yl (2e)-2-methylbut-2-enoate
trimethyl[2-(pyridine-3-carbonyloxy)ethyl]azanium
[C11H17N2O2]+ (209.12899620000002)
n-[(2z)-2-[(2e,4e)-undeca-2,4-dien-1-ylidene]hydrazin-1-ylidene]hydroxylamine
C11H19N3O (209.15280439999998)